1 Min Read
April 3 (Reuters) - Cellectar Biosciences Inc:
* CELLECTAR ANNOUNCES ISSUANCE OF U.S. PATENT COVERING CLR 131 USE IN MULTIPLE MYELOMA Source text for Eikon: Further company coverage:
All quotes delayed a minimum of 15 minutes. See here for a complete list of exchanges and delays.
© 2018 Reuters. All Rights Reserved.